Navigation Links
Visual Healthcare Provides Fourth Quarter Revenue Guidance

RENO, Nev., June 15, 2011 /PRNewswire/ -- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) is pleased to be able to announce today that it expects revenues for the fourth quarter of fiscal 2011 to be between $1,050,000 and $1,150,000. The mid-range of the current guidance is a record high since inception and represents a substantial increase from previous quarters in 2011. Based on these figures the Company can provide further guidance regarding year end revenues for the entire year which is expected to be between $1,460,000 and $1,550,000.

Final year end results will be released on August 30th, 2011. The Company will hold a conference call to discuss 2011 financial results Wednesday, August 31st, 2011, at 11:00 AM EDT. Contact information will be provided on company website.

Company Chairman, Mr. Gerard Dab largely credits changing conditions in the American healthcare market, including new regulations, for the company performance in 2011. New products and services have been ushered in but would not have been as well received if the market had not been more receptive than ever before in the company's 12 year history.


Visual Healthcare Corp., since 1998, designs, creates and develops innovative information platforms, specifically conceived for the automation of a wide range of scientific disciplines. These include pharmaceutical research, clinical trials, laboratory automation, true quality assurance tools, total quality control applications.  They also include quantitative analytic tools such as proprietary frameworks for electronic health records, electronic prescription, infection and disease control, and smart cancer registries. The company's extensive portfolio of proprietary technologies is the result of a unique collaboration between senior clinicians from the McGill University Faculty of Medicine and affiliated tertiary care centers, medical software architects, and a Fortune 100 healthcare service company, investing some $50 million in the process. The Company licenses its technology to operating companies in exchange for an equity stake or a royalty stream. It owns significant stakes in various companies including VisualMED Clinical Solutions Corp. (NASDAQ OTC: VMCS), a leader in the field of electronic health records.

For more information, please visit:


Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.


Gerard Dab, CEO
Visual Healthcare Corp.

SOURCE Visual Healthcare Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In a New Audio Interview at, Gerard Dab, Chairman and CEO of Visual Healthcare Corp., Provides Details Regarding Recent News
2. Increased Demand for Visual Healthcare ADE Prevention Platform
3. Boston Scientifics SpyGlass® Direct Visualization System Achieves Global Utilization Milestones
4. Visual Healthcare to Support Chinese Clinical Trials
5. SpineSmith Successful in VisuALIF Alpha Launch
6. Two Laser Balloon Live Cases Shed New Light on Direct Visualization and PV Ablation
7. Chemistry Researchers Create New Tool to Visualize Bloodstains
8. The Truth About Diabetes and Visual Complications Unveiled
9. Reportlinker Adds Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others
10. SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting
11. NIST-traceable Temperature Tracking Provides Visual Alert RadarFind Sensor Now Waterproof Certified
Post Your Comments:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):